All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”
7F14061

Phosphorylation-mediated signalling in DNA damage response and cancer

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

    EEA/Norwegian Financial Mechanism

  • Call for proposals

    Finanční mechanismy EHP/Norsko 1 (SMSM20147F1)

  • Main participants

    Ústav molekulární genetiky AV ČR, v. v. i.

  • Contest type

    VS - Public tender

  • Contract ID

    MSMT/28477/2014

Alternative language

  • Project name in Czech

    Phosphorylation-mediated signalling in DNA damage response and cancer

  • Annotation in Czech

    In this application we will investigate the following five aims: Aim I) Molecular mechanism of PPM1D/Wip1 phosphatase function in DDR Aim II) Role of truncating PPM1D mutations in colorectal cancer Aim III) Functional role of PP1 phosphatase in DNA damage checkpoints and repair Aim IV) Novel role of ATR-Chk1-Aurora-A signalling in Fanconi anemia pathway Aim V) Molecular mechanism of Cdc7 kinase-dependent replisome stabilization

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    FD - Oncology and haematology

  • CEP - secondary branch

  • CEP - another secondary branch

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    30204 - Oncology<br>30205 - Hematology

Completed project evaluation

  • Provider evaluation

    V - Vynikající výsledky projektu (s mezinárodním významem atd.)

  • Project results evaluation

    The PHOSCAN project may be deemed to be executed. In addition to above described, researchers found that cancer cells that carry genetic changes in studied pathways are more sensitive to chemotherapy whereas others do not respond well to the treatment. Finding of such a caliber will contribute to better prediction of therapeutic response and design targeted cancer treatment. Scientific quality of all participating teams and their international recognition is high. Consortium achieved several clinically relevant observations published in high level scientific journals. Overall project rating is therefore outstanding.

Solution timeline

  • Realization period - beginning

    Aug 7, 2014

  • Realization period - end

    Apr 30, 2017

  • Project status

    U - Finished project

  • Latest support payment

    Mar 15, 2017

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP18-MSM-7F-U/05:1

  • Data delivery date

    Nov 21, 2018

Finance

  • Total approved costs

    25,520 thou. CZK

  • Public financial support

    25,520 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK